BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22953430)

  • 1. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
    Westerberg PA; Linde T; Ljunggren O
    Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical utility of systemic venous sampling of FGF23 for identifying tumours responsible for tumour-induced osteomalacia.
    Ito N; Shimizu Y; Suzuki H; Saito T; Okamoto T; Hori M; Akahane M; Fukumoto S; Fujita T
    J Intern Med; 2010 Oct; 268(4):390-4. PubMed ID: 20698924
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
    Seemann L; Padala SA; Mohammed A; Belayneh N
    J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumor-induced rickets/osteomalacia].
    Fukumoto S
    Nihon Rinsho; 2006 Jun; Suppl 2():96-9. PubMed ID: 16817359
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumour-induced osteomalacia.
    Minisola S; Peacock M; Fukumoto S; Cipriani C; Pepe J; Tella SH; Collins MT
    Nat Rev Dis Primers; 2017 Jul; 3():17044. PubMed ID: 28703220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic osteomalacia: two case reports with surprisingly different outcomes.
    Seijas R; Ares O; Sierra J; Pérez-Dominguez M
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):533-9. PubMed ID: 19125258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced osteomalacia.
    Fukumoto S
    Panminerva Med; 2024 Jun; 66(2):188-197. PubMed ID: 38127062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-induced osteomalacia combined with increased bone resorption postoperatively: A case report.
    Shi L; Tang M; Duan S; Deng F; Zhang Y; Yang J; Hu J
    Medicine (Baltimore); 2023 Jul; 102(27):e34217. PubMed ID: 37417620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced osteomalacia: experience from a South American academic center.
    González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
    Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
    Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
    Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
    Vollmer S; Olsson K
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38697682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor-induced hypophosphatemic osteomalacia].
    Ito N; Fukukmoto S
    Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
    [No Abstract]   [Full Text] [Related]  

  • 14. [FGF23 tumor induced osteomalacia with localization of neoplasm in the tympanic cavity].
    Ovchinnikov AY; Khon EM; Bakotina AV; Miroshnichenko NA; Gronskaia SA; Belaya ZE
    Vestn Otorinolaringol; 2023; 88(6):91-96. PubMed ID: 38153899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
    Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
    Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypophosphatemic osteomalacia].
    Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
    Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Induced Osteomalacia.
    Florenzano P; Hartley IR; Jimenez M; Roszko K; Gafni RI; Collins MT
    Calcif Tissue Int; 2021 Jan; 108(1):128-142. PubMed ID: 32504138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-induced osteomalacia.
    Chong WH; Molinolo AA; Chen CC; Collins MT
    Endocr Relat Cancer; 2011 Jun; 18(3):R53-77. PubMed ID: 21490240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-induced osteomalacia: a rare cause of chronic pain and weakness.
    Nasr JT; Tohme J; Collins MT; Drake MT; Hartley IR; Sfeir J; Dockery K; Taskin M
    Pract Neurol; 2022 Dec; 22(6):528-531. PubMed ID: 35896375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.